Search results
Crypto analysts warn of Andrew Tate's DADDY coin as signs of insider trading mount
The Forex Market· 3 days agoOn-chain data tracker Bubblemaps identified insider trading activity in the token DADDY, Andrew Tate...
Enanta Pharmaceuticals executive sells over $89k in company stock By Investing.com
Investing.com· 6 hours agoThe transaction, completed on June 17, 2024, fetched a total of $89,589, with the shares sold at a...
Corbus Pharmaceuticals Board Member To Sell Shares In Planned Trading - Corbus Pharmaceuticals...
Benzinga· 13 hours agoIn a recent move signaling strategic financial planning, Corbus Pharmaceuticals Holdings, Inc. CRBP...
UPDATE: Shadow Trading Court to Weigh Competing Post-Trial Motions | JD Supra
JD Supra· 6 days agoThe SEC secured a jury verdict finding Matthew Panuwat liable for violating insider trading laws on April 5, 2024 after an eight-day trial. Panuwat has ...
Puma biotechnology executive sells $89.8k in stock By Investing.com
Investing.com· 7 hours ago(NASDAQ:PBYI), has sold a total of 27,000 shares of the company's common stock, according to a...
An ‘atomic bomb’ just fell on one of America's most powerful party bosses
Politico via Yahoo News· 9 hours agoOne of America’s most deeply entrenched political machines is finally coming apart. New Jersey...
ProKidney (NASDAQ:PROK) Shares Gap Up on Insider Buying Activity
ETF DAILY NEWS· 5 hours agoShares of ProKidney Corp. (NASDAQ:PROK – Get Free Report) gapped up before the market opened on Monday following insider buying activity. Specifically, insider< ...
Shady Days: SEC Secures Another Insider Trading Stat on Shadow Trading Theory | JD Supra
JD Supra· 7 days agoThe settlement is notable as the second instance of the SEC bringing an enforcement action for insider trading under the so-called "shadow trading" theory. According to the ...
Crude Oil Moves Higher; Vera Bradley Shares Slide - Avidity Biosciences (NASDAQ:RNA)
Benzinga· 5 days agoU.S. stocks traded higher toward the end of trading, with the S&P 500 surging around 1% on...
Aprea Therapeutics (NASDAQ:APRE) Given “Buy” Rating at HC Wainwright
ETF DAILY NEWS· 19 hours agoAprea Therapeutics (NASDAQ:APRE – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued to investors on Monday, Benzinga reports ...